Works
Developing a new classification model for efficient compound selection with 5-HT2A antagonistic activity. |
Integration of molecular modeling and machine learning techniques for precise identification of PDE10A inhibitors |
Evaluation of Progression-Free Survival in Patients with Metastatic Bowel Cancer After First-Line Systemic Therapy at Pauls Stradiņš Clinical University Hospital from 2018 to 2023 |
a 3D printed wound dressing with antibacterial effects |
Synthesis of NLX-219 analogs containing new structural bicyclic motif. |
Synthesis of chiral 2-(iodomethyl)- and 2-(aminomethyl)- benzodioxane, a crucial building block for derivatives possessing high and selective affinities for D2-like and 5-HT1A receptors. |
Evaluating the antiamnestic potential of the novel 2-methoxyphenylpiperazine derivative, HBK-14, against scopolamine- and MK-801-induced memory deficits in mice |
Pharmaceutical gummies as an extemporaneous platform for the administration of modified release pellets to pediatric patients |
Brain-Derived Neurotrophic Factor in Multiple Sclerosis Disability: A Prospective Study |
Off-label drug use series: A rare case of a malignant benignancy |
Off-label drug use series: A rare case of an early onset hepatocellular carcinoma |
Transplant-Associated Thrombotic Microangiopathy as a Consequence of Graft-versus-Host Disease and Cyclosporine Administration after Hematopoietic Stem Cell Transplantation |